BiotechTube
Home/Authera/Hans Petter Tjeldflaat
HP

Hans Petter Tjeldflaat

CFO

Authera

Roles

CFOatAuthera
CFOatAuthera

Therapeutic Areas

OphthalmologyImmunology

Authera Pipeline

DrugIndicationPhase
AuT-1Exudative eye diseases (e.g., wet AMD, diabetic macular edema)Pre-clinical
Undisclosed PipelineNot Specified (FcRn biology-based)Pre-clinical
UndisclosedNot SpecifiedPre-clinical

Leadership Team at Authera

SM
Simone Mester
CEO & Co-founder
TT
Torleif T. Gjølberg
CSO & Co-founder
GC
Gaia Calamera
Lead Senior Scientist
MA
Milena A. Blaga
Senior Scientist
JS
Jenny Skjermo Telstad
Associate Scientist
JT
Jan Terje Andersen
Chairman of the Board & Co-founder
IS
Inger Sandlie
Board Member & Co-founder
ES
Eirik Sundlisæter
Medical Advisor
SM
Simone Mester
CEO & Co-founder
TT
Torleif T. Gjølberg
CSO & Co-founder
View full Authera profile